Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/molecules26113255

http://scihub22266oqcxt.onion/10.3390/molecules26113255
suck pdf from google scholar
34071479!8198152!34071479
unlimited free pdf from europmc34071479    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34071479      Molecules 2021 ; 26 (11): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator #MMPMID34071479
  • Bellotti D; Remelli M
  • Molecules 2021[May]; 26 (11): ä PMID34071479show ga
  • Deferoxamine B is an outstanding molecule which has been widely studied in the past decade for its ability to bind iron and many other metal ions. The versatility of this metal chelator makes it suitable for a number of medicinal and analytical applications, from the well-known iron chelation therapy to the most recent use in sensor devices. The three bidentate hydroxamic functional groups of deferoxamine B are the centerpiece of its metal binding ability, which allows the formation of stable complexes with many transition, lanthanoid and actinoid metal ions. In addition to the ferric ion, in fact, more than 20 different metal complexes of deferoxamine b have been characterized in terms of their chemical speciation in solution. In addition, the availability of a terminal amino group, most often not involved in complexation, opens the way to deferoxamine B modification and functionalization. This review aims to collect and summarize the available data concerning the complex-formation equilibria in solutions of deferoxamine B with different metal ions. A general overview of the progress of its applications over the past decade is also discussed, including the treatment of iron overload-associated diseases, its clinical use against cancer and neurodegenerative disorders and its role as a diagnostic tool.
  • |Animals[MESH]
  • |Antineoplastic Agents/pharmacology[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Chelating Agents/*chemistry/pharmacology[MESH]
  • |Chemistry, Pharmaceutical/methods[MESH]
  • |Deferoxamine/*chemistry[MESH]
  • |Electrochemistry/methods[MESH]
  • |Electrolytes[MESH]
  • |Humans[MESH]
  • |Hydrogen-Ion Concentration[MESH]
  • |Ions[MESH]
  • |Iron Chelating Agents/chemistry[MESH]
  • |Iron Overload/drug therapy[MESH]
  • |Iron/metabolism[MESH]
  • |Kinetics[MESH]
  • |Ligands[MESH]
  • |Metals/chemistry[MESH]
  • |Neoplasms/drug therapy[MESH]
  • |Potentiometry[MESH]
  • |SARS-CoV-2[MESH]
  • |Temperature[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box